Special Session 1: Implications of Methylation and Genomics in Skull Base Pathology
17th February, 2023, 07:30 - 08:30
Tampa Bay 9

Treatment options for skull base pathologies have primarily focused on surgery and radiation. However, with advancing knowledge of methylation and genomics in skull base pathologies, further treatment options and risks stratification of these tumors may aid in how these tumors are managed. This session will focus on providing an update on emerging data regarding methylation and genomics in skull base pathology and how these will be used to further patient care. Any provider who cares for these tumors is encouraged to attend.

Objectives

At the conclusion of this session, attendees will be able to:

• Recognize the role methylation and genomics play in skull base pathologies.
• Distinguish which patients are appropriate for pathology testing and how the results of testing will impact patient care.
• Identify where to find active clinical trials that utilize methylation and genomics in skull base pathology.

---

Current Schedule

As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names

Speaker	Title	Role	Times
Stephen Magill 415-443-6084		Moderator	-
Diana Bell 713-792-2041		Moderator	-
Lisa Rooper 4109553580	Role of Methylation and Genomics in Skull Base Pathology	Speaker	7:30 am - 7:40 am
Wenya Linda Bi 617-525-8319	Skull Base Tumor Microenvironment	Speaker	7:40 am - 7:50 am
Georgios Zenonos 412-627-4346	Genomics in Chordoma	Speaker	7:50 am - 8:00 am
Tomas Garzon-Muvdi 4436765651	Methylation and Genomics in Head and Neck Cancer of the Skull Base	Speaker	8:00 am - 8:10 am
	Q&A		8:10 am - 8:30 am